Updated on 6 August 2012
What are the future growth plans of TLC?
Taiwan is a small country with limited means and exposure. TLC is headquartered in Taiwan, with plans to expand operations to China and Japan by setting up subsidiary offices for the ease of penetrating into the market and be more familiarized with the local regulatory changes. We position ourselves as a specialty biopharmaceutical company focusing on lipid-based drug delivery technologies in injectable drugs.
We are hoping to establish ourselves in the global arena for further development and collaboration opportunities.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
